Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne L Bergmann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Biochemistry|March 24, 2020
Highly sensitive LC-MS/MS analysis of catecholamines in plasmaMarianne L Bergmann, Anne Schmedes
The Journal of Biological Chemistry|January 29, 2010
Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptorsAnders A Jensen, Marianne L Bergmann, Tommy Sander, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 27, 2026
Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorderMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Diabetologia|August 2, 2019
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trialMalin Nilsson, Nicole Jensen, Michael Gejl, et al.
Alcohol, Clinical & Experimental Research|March 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumptionMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Clinical Physiology and Functional Imaging|December 31, 2021
Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [<sup>123</sup> I]MIBG heart scintigraphyLotte Lindberg, Louise S Brinth, Marianne L Bergmann, et al.
Journal of Medicinal Chemistry|April 2, 2010
Novel 4-(piperidin-4-yl)-1-hydroxypyrazoles as gamma-aminobutyric acid(A) receptor ligands: synthesis, pharmacology, and structure-activity relationshipsHenriette A Møller, Tommy Sander, Jesper L Kristensen, et al.
Nature Neuroscience|June 24, 2008
The binding sites for cocaine and dopamine in the dopamine transporter overlapThijs Beuming, Julie Kniazeff, Marianne L Bergmann, et al.
Diabetes|May 5, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover StudyNikolaj E Sørum, Julie Warnøe, Jens J Holst, et al.
The Journal of Nutrition|June 4, 2025
High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 DiabetesJakob L Wetche, Anne V Schmedes, Amalie Sjøgren, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Biochemistry|March 24, 2020
Highly sensitive LC-MS/MS analysis of catecholamines in plasmaMarianne L Bergmann, Anne Schmedes
The Journal of Biological Chemistry|January 29, 2010
Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptorsAnders A Jensen, Marianne L Bergmann, Tommy Sander, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 27, 2026
Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorderMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Diabetologia|August 2, 2019
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trialMalin Nilsson, Nicole Jensen, Michael Gejl, et al.
Alcohol, Clinical & Experimental Research|March 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumptionMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Clinical Physiology and Functional Imaging|December 31, 2021
Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [<sup>123</sup> I]MIBG heart scintigraphyLotte Lindberg, Louise S Brinth, Marianne L Bergmann, et al.
Journal of Medicinal Chemistry|April 2, 2010
Novel 4-(piperidin-4-yl)-1-hydroxypyrazoles as gamma-aminobutyric acid(A) receptor ligands: synthesis, pharmacology, and structure-activity relationshipsHenriette A Møller, Tommy Sander, Jesper L Kristensen, et al.
Nature Neuroscience|June 24, 2008
The binding sites for cocaine and dopamine in the dopamine transporter overlapThijs Beuming, Julie Kniazeff, Marianne L Bergmann, et al.
Diabetes|May 5, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover StudyNikolaj E Sørum, Julie Warnøe, Jens J Holst, et al.
The Journal of Nutrition|June 4, 2025
High Plasma 18β-Glycyrrhetinic Acid Levels Are Associated With More Intensive Antihypertensive Treatment, Resistant Hypertension and Apparent Mineralocorticoid Excess in Patients With Type 2 DiabetesJakob L Wetche, Anne V Schmedes, Amalie Sjøgren, et al.
Pageof 1